RxDoctor Payments DataLook up a doctor →

David Guzman

Internal Medicine · Los Angeles, CANPI 1275521494

Payments from drug & device makers

$4,325,693in general payments, 2019–2025

Across 1,721 payments — averaging $2513.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$2.1M
  • Novo Nordisk AS$394K
  • Sanofi Pasteur Inc.$394K
  • Regeneron$307K
  • AstraZeneca$262K
  • Boehringer Ingelheim$216K
  • plus $659K from 15 others
$4,501in research payments, 2019–2025

Across 25 payments — averaging $180.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Corcept Therapeutics$3K
  • Regeneron$2K

What the payments were for

  • Travel & lodging$10,68975%
  • Food & beverage$3,62225%
  • Education$320%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,325,693 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Other internal medicine in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →